Rachel Katzenellenbogen named co-leader of CPC research program at IU Simon Comprehensive Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Rachel Katzenellenbogen was named a co-leader of the Cancer Prevention and Control research program at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center. 

She serves along with Susan Rawl and Todd Skaar.

A member of the program since 2018, Katzenellenbogen is the chief of the Division of Adolescent Medicine in the Department of Pediatrics, associate professor of pediatrics and of microbiology and immunology, and the Richard E. and Pauline P. Klingler Scholar in Pediatrics at IU School of Medicine. She is also the Chuck and Tina Pagano Scholar at the cancer center.

Katzenellenbogen’s cancer research focuses on the fundamental way human papillomavirus drives cancer development and progression, how that drive is common to all cancers or is unique to this infection-associated cancer, and identifying ways to detect and disrupt these pathways to intervene early in treatment.

Before joining IU, Katzenellenbogen was an associate professor of pediatrics at the University of Washington and Seattle Children’s Research Institute. 

Table of Contents

YOU MAY BE INTERESTED IN

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more

Login